Angiocrine Bioscience Revenue and Competitors
Estimated Revenue & Valuation
- Angiocrine Bioscience's estimated annual revenue is currently $5.3M per year.
- Angiocrine Bioscience's estimated revenue per employee is $155,000
Employee Data
- Angiocrine Bioscience has 34 Employees.
- Angiocrine Bioscience grew their employee count by -17% last year.
Angiocrine Bioscience's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP, Clinical Operations | Reveal Email/Phone |
3 | Chief Scientific Officer | Reveal Email/Phone |
4 | Execuvite Director Preclinical Development | Reveal Email/Phone |
5 | Associate Director Clinical Operations | Reveal Email/Phone |
6 | Senior Director, Technical Operations | Reveal Email/Phone |
7 | Director, Clinical Operations | Reveal Email/Phone |
8 | Senior Director, Project Management | Reveal Email/Phone |
9 | Director Quality, Cell Therapy | Reveal Email/Phone |
10 | Chief Operating Officer | Reveal Email/Phone |
Angiocrine Bioscience Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Angiocrine Bioscience?
Angiocrine Bioscience is a private, clinical stage cell and gene therapy company harnessing the power of genetically modified human endothelial cells to regenerate tissues, restore function and rejuvenate patients with serious medical conditions. Our team is developing a pipeline of proprietary engineered endothelial cell (E-CEL® ) therapies for treating multiple life-threatening hemato-oncologic and immunologic conditions, as well as, regenerating tissues and organs that have been injured or damaged by diseases.
keywords:N/AN/A
Total Funding
34
Number of Employees
$5.3M
Revenue (est)
-17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $9.5M | 34 | 6% | N/A |
#2 | $5.7M | 34 | -8% | N/A |
#3 | $3.9M | 34 | N/A | N/A |
#4 | $2.6M | 34 | 31% | $43M |
#5 | $3.6M | 34 | -41% | $132.5M |